107 related articles for article (PubMed ID: 25752319)
1. Body composition, pre-diabetes and cardiovascular disease risk in early schizophrenia.
Strassnig M; Clarke J; Mann S; Remington G; Ganguli R
Early Interv Psychiatry; 2017 Jun; 11(3):229-236. PubMed ID: 25752319
[TBL] [Abstract][Full Text] [Related]
2. Oral glucose tolerance test performance in olanzapine-treated schizophrenia-spectrum patients is predicted by BMI and triglycerides but not olanzapine dose or duration.
Guina J; Roy S; Gupta A; Langleben DD; Elman I
Hum Psychopharmacol; 2017 Jul; 32(4):. PubMed ID: 28573760
[TBL] [Abstract][Full Text] [Related]
3. [Metabolic side effects of risperidone in early onset schizophrenia].
Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
[TBL] [Abstract][Full Text] [Related]
4. Hyperglycemia and diabetes in patients with schizophrenia or schizoaffective disorders.
Cohen D; Stolk RP; Grobbee DE; Gispen-de Wied CC
Diabetes Care; 2006 Apr; 29(4):786-91. PubMed ID: 16567816
[TBL] [Abstract][Full Text] [Related]
5. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
6. Cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders: baseline results from the RAISE-ETP study.
Correll CU; Robinson DG; Schooler NR; Brunette MF; Mueser KT; Rosenheck RA; Marcy P; Addington J; Estroff SE; Robinson J; Penn DL; Azrin S; Goldstein A; Severe J; Heinssen R; Kane JM
JAMA Psychiatry; 2014 Dec; 71(12):1350-63. PubMed ID: 25321337
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance, beta cell function and cardiovascular risk factors in Ghanaians with varying degrees of glucose tolerance.
Amoah AG; Schuster DP; Gaillard T; Osei K
Ethn Dis; 2002; 12(4):S3-10-7. PubMed ID: 12477148
[TBL] [Abstract][Full Text] [Related]
8. Effect of antipsychotic-induced hyperprolactinemia on anthropometric measures, insulin sensitivity and lipid profile in patients with schizophrenia or related psychoses.
Melkersson K; Berinder K; Hulting AL
Neuro Endocrinol Lett; 2011; 32(4):428-36. PubMed ID: 21876517
[TBL] [Abstract][Full Text] [Related]
9. Fasting insulin sensitivity and post-oral glucose hyperinsulinaemia related to cardiovascular risk factors in adolescents with precocious pubarche.
Potau N; Williams R; Ong K; Sánchez-Ufarte C; de Zegher F; Ibáñez L; Dunger D
Clin Endocrinol (Oxf); 2003 Dec; 59(6):756-62. PubMed ID: 14974918
[TBL] [Abstract][Full Text] [Related]
10. Blood levels of glucose and insulin and insulin resistance in patients with schizophrenia on clozapine monotherapy.
Wysokiński A
Diabetes Metab Syndr; 2014; 8(4):236-41. PubMed ID: 25311817
[TBL] [Abstract][Full Text] [Related]
11. Body fat distribution and their associations with cardiovascular risk, insulin resistance and β-cell function: are there differences between men and women?
Chen G; Liu C; Chen F; Yao J; Jiang Q; Chen N; Huang H; Liang J; Li L; Lin L
Int J Clin Pract; 2011 May; 65(5):592-601. PubMed ID: 21489083
[TBL] [Abstract][Full Text] [Related]
12. GH peak response to GHRH-arginine: relationship to insulin resistance and other cardiovascular risk factors in a population of adults aged 50-90.
Carmichael JD; Danoff A; Milani D; Roubenoff R; Lesser ML; Livote E; Reitz RE; Ferris S; Kleinberg DL
Clin Endocrinol (Oxf); 2006 Aug; 65(2):169-77. PubMed ID: 16886956
[TBL] [Abstract][Full Text] [Related]
13. Visceral fat is strongly associated with post-transplant diabetes mellitus and glucose metabolism 1 year after kidney transplantation.
von Düring ME; Jenssen T; Bollerslev J; Åsberg A; Godang K; Hartmann A
Clin Transplant; 2017 Jan; 31(1):. PubMed ID: 27859633
[TBL] [Abstract][Full Text] [Related]
14. Contributions of total and regional fat mass to risk for cardiovascular disease in older women.
Van Pelt RE; Evans EM; Schechtman KB; Ehsani AA; Kohrt WM
Am J Physiol Endocrinol Metab; 2002 May; 282(5):E1023-8. PubMed ID: 11934666
[TBL] [Abstract][Full Text] [Related]
15. A cross-sectional evaluation of adiponectin plasma levels in patients with schizophrenia and schizoaffective disorder.
Hanssens L; van Winkel R; Wampers M; Van Eyck D; Scheen A; Reginster JY; Collette J; Peuskens J; De Hert M
Schizophr Res; 2008 Dec; 106(2-3):308-14. PubMed ID: 18930377
[TBL] [Abstract][Full Text] [Related]
16. Visceral fat is better related to impaired glucose metabolism than body mass index after kidney transplantation.
von Düring ME; Jenssen T; Bollerslev J; Åsberg A; Godang K; Eide IA; Dahle DO; Hartmann A
Transpl Int; 2015 Oct; 28(10):1162-71. PubMed ID: 25970153
[TBL] [Abstract][Full Text] [Related]
17. Lean mass and insulin resistance in women with polycystic ovary syndrome.
Comerford KB; Almario RU; Kim K; Karakas SE
Metabolism; 2012 Sep; 61(9):1256-60. PubMed ID: 22424820
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment Cardiometabolic Status in Youth With Early-Onset Psychosis: Baseline Results From the TEA Trial.
Jensen KG; Correll CU; Rudå D; Klauber DG; Stentebjerg-Olesen M; Fagerlund B; Jepsen JRM; Fink-Jensen A; Pagsberg AK
J Clin Psychiatry; 2017; 78(8):e1035-e1046. PubMed ID: 28102978
[TBL] [Abstract][Full Text] [Related]
19. Adiposity and insulin sensitivity derived from intravenous glucose tolerance tests in antipsychotic-treated patients.
Haupt DW; Fahnestock PA; Flavin KA; Schweiger JA; Stevens A; Hessler MJ; Maeda J; Yingling M; Newcomer JW
Neuropsychopharmacology; 2007 Dec; 32(12):2561-9. PubMed ID: 17375138
[TBL] [Abstract][Full Text] [Related]
20. Comparison of regional fat mass measurement by whole body DXA scans and anthropometric measures to predict insulin resistance in women with polycystic ovary syndrome and controls.
Glintborg D; Petersen MH; Ravn P; Hermann AP; Andersen M
Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1235-1243. PubMed ID: 27529295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
